American Screening← All resources
Home ResourcesTesting Methods
Testing Methods · 7 min read

CLIA-Waived vs Lab-Based Testing Explained

Buyers often frame onsite screening and laboratory testing as an either-or choice. They are not. CLIA-waived devices give you a fast preliminary answer at the point of care, and lab-based confirmatory testing gives you a definitive one when the stakes require it. Used together, they are faster and cheaper than sending every specimen to a lab.

This guide explains what CLIA-waived status actually means, what a Certificate of Waiver allows your site to do, and how onsite and lab-based testing fit into a single compliant workflow.

What CLIA-waived actually means

CLIA is the federal framework that governs laboratory testing on human specimens. A device is CLIA-waived when it is simple enough, and low enough risk, that a site can run it under a Certificate of Waiver rather than a full laboratory license. Most onsite cups, dip cards, and oral-fluid devices used in clinics are marketed as CLIA-waived for that reason.

A waiver is not a license to run any test. It authorizes waived-complexity devices used exactly as the manufacturer instructs. Deviating from the instructions can take a waived test out of its waived status, which is why staff training on the specific device matters.

What onsite CLIA-waived screening is good at

Onsite screening gives you a result in minutes, at the point of care, for a few dollars per device. That speed is the entire value: it lets you triage a large number of specimens quickly, make same-visit decisions, and only escalate the results that need a definitive answer. It is preliminary by design.

What lab-based confirmatory testing adds

Laboratory confirmation, typically by GC-MS or LC-MS, identifies and quantifies a specific substance with far greater specificity than an immunoassay screen. It is the method that distinguishes a true positive from a cross-reacting compound, and it is what stands up in an employment or forensic context. It is slower and more expensive, which is exactly why you reserve it for the specimens that need it.

How the two fit together

The standard workflow is screen first, confirm when needed. Run the CLIA-waived device onsite; negatives are typically final for your purposes, and non-negatives are sent to the lab for confirmatory testing before any consequential decision is made. This screen-then-confirm model is the backbone of DOT and most defensible non-DOT programs.

Put it into practice
DOT vs Non-DOT Workplace Testing How to Read Rapid Test Results and Confirmatory Testing
Request wholesale pricing →

FAQ

Is a CLIA-waived result good enough on its own?

For a negative, usually yes for screening purposes. A non-negative CLIA-waived result is preliminary and should be confirmed by a laboratory method such as GC-MS or LC-MS before it is used for any consequential decision, particularly in employment or forensic contexts.

What does a Certificate of Waiver allow a clinic to do?

It allows the site to run CLIA-waived complexity devices, used exactly as the manufacturer instructs, without a full laboratory license. It does not authorize higher-complexity testing, and departing from the manufacturer's instructions can remove a test from its waived status.

Source from a supplier that stands behind every lot.

CLIA-waived and FDA 510(k)-cleared devices, SAMHSA cutoff calibration, same-day U.S. shipping, and white-label fulfillment. Register your organization for instant wholesale access.

Request wholesale pricing →View testing standards
Keep reading
9 Questions to Ask Before Choosing a Screening Supplier
Choosing a screening supplier is a due-diligence decision. These nine questions separate a real screening partner from a reseller with a website.
How to Read Rapid Test Results and Confirmatory Testing
The counterintuitive rule of rapid tests: any line, even a faint one, means negative. Here is how to read results correctly and when a specimen has to go to the lab.